
OCREVUS
OCREVUS (ocrelizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells. This may help to protect healthy cells from damage. Specifically, it is a CD20-cytolytic antibody for the treatment of Multiple Sclerosis (MS).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Multiple Sclerosis
Prescribed by
Neurologists
How it’s administered
Intravenous (IV) infusion
Frequency
Once every six months
Length of treatment
Five hours or more